Question follow-through · 99113
Health Services: Waiting Lists
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that NHS trusts do not manage referral pipelines, triage processes, or administrative allocation methods in ways that reduce the apparent size of the elective waitin
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 10 Dec 2025
- Target answer date
- 15 Dec 2025
- Answer
- 18 Dec 2025 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Puberty Suppressing Hormones: Clinical Trials · 15 Dec 2025
- Puberty Suppressing Hormones: Clinical Trials · 15 Dec 2025
- Puberty Suppressing Hormones: Clinical Trials · 15 Dec 2025
- Puberty Suppressing Hormones: Clinical Trials · 15 Dec 2025
- Puberty Suppressing Hormones: Clinical Trials · 15 Dec 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
10 Dec 2025
Question tabled
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that NHS trusts do not manage referral pipelines, triage processes, or administrative allocation methods in ways that reduce the apparent size of the elective waitin
15 Dec 2025
Target answer date
Date supplied by the official written-questions record.
18 Dec 2025
Answer published
For referral to treatment (RTT) pathways that start within an interface service, which is any form of intermediary clinical triage, assessment, and/or treatment between primary and secondary care, a patient's clock start will begin at the point the genera...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether Ministers approved the commencement of the PATHWAYS puberty blocker trial.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what indemnity arrangements are in place for clinicians involved in prescribing puberty blockers under the PATHWAYS trial.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what role NHS England played in determining the eligibility criteria for children recruited into the PATHWAYS trial.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether the Department has received formal representations from professional medical bodies regarding the PATHWAYS trial since ethical approval was granted.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what data sharing agreements are in place governing access to PATHWAYS trial participant data by external researchers or academic institutions.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment has been made of the compatibility of the PATHWAYS trial with the Cass Review recommendations on clinical caution and evidence thresholds.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether children previously discharged from NHS gender services will be eligible for the PATHWAYS trial.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that the PATHWAYS trial does not adversely affect a participant’s future access to NHS care.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, which international clinical guidelines were used in the design of the PATHWAYS trial.
Puberty Suppressing Hormones: Clinical Trials
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what steps he plans to take to ensure that Parliament is provided with adequate opportunities for scrutinising progress and outcomes of the PATHWAYS trial while it is ongoing.
Medicine: Publications
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of peer reviewed medical journals publishing articles that propose alternative terminology for practices that are criminal offences i
Female Genital Mutilation
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether his Department was consulted prior to the publication of the British Medical Journal article concerning terminology used in relation to female genital mutilation.